U.S. equities finished Wednesday modestly higher, according to market data from BIT (Bit.com), with the Dow Jones Industrial Average up 0.22%, the S&P 500 gaining 0.21%, and the Nasdaq rising 0.16%. The standout move came from Moderna, which jumped 176.9%, while Merck added 12.6% after the two companies said their jointly developed personalized mRNA cancer vaccine, intismeran autogene, formerly known as mRNA-4157/V940, combined with Merck’s immunotherapy drug Keytruda, met the primary endpoint and key secondary endpoint in the Phase III INTerpath-001 trial for patients with high-risk melanoma. Semiconductor-related names showed mixed trading, with Marvell Technology up more than 9.8%, SK Hynix up 0.35%, Sandisk down 3.5%, and Micron Technology off 0.39%. Crypto-related stocks also posted strong gains. Strategy rose 11.95% to $103.58 after climbing more than 13% intraday. Coinbase gained 9.05% to $159.47, stablecoin issuer Circle advanced 9.44% to $78.50, and Ethereum treasury company BitMine rose 9.68% to $20.05.
U.S. stocks ended Wednesday slightly higher, according to market data from BIT (Bit.com), with the Dow Jones Industrial Average up 0.22%, the S&P 500 adding 0.21%, and the Nasdaq rising 0.16%.
Among individual names, Moderna (MRNA.O) surged 176.9%, while Merck (MRK.N) gained 12.6%. The two companies said their jointly developed personalized mRNA cancer vaccine, intismeran autogene, previously known as mRNA-4157/V940, combined with Merck’s immunotherapy drug Keytruda, met the primary endpoint and key secondary endpoint in the Phase III INTerpath-001 trial involving patients with high-risk melanoma.
Chip-related stocks were mixed. Marvell Technology (MRVL.O) rose more than 9.8%, SK Hynix (SKHY.O) gained 0.35%, Sandisk (SNDK.O) fell 3.5%, and Micron Technology (MU.O) slipped 0.39%.
Crypto-linked stocks moved sharply higher as well. Strategy climbed 11.95% to $103.58 and was up more than 13% at one point during the session. Coinbase rose 9.05% to $159.47. Stablecoin issuer Circle gained 9.44% to $78.50, while Ethereum treasury company BitMine advanced 9.68% to $20.05.
This article was originally published by Bit.Fan. For more cryptocurrency news and market insights, visit www.bit.fan. Disclaimer:
The market information, project data, and third-party content displayed on this platform are for industry information sharing only and do not constitute any form of investment advice or return commitment.
Cryptocurrency trading carries high risks. Users should fully assess their risk tolerance and make independent decisions. All profits, losses, and legal responsibilities are borne by the users themselves.
